What You Need to Know about the COVID-19 Booster | NorthShore
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study - The Lancet
Study: COVID booster effectiveness wanes but remains strong | AP News
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
COVID Vaccine Booster Efficacy Against Infection May Fade Quickly | MedPage Today
Covid booster vaccines effective against severe illness from omicron, CDC says
Moderna COVID vaccine booster dose results in immune memory
Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12–17 years in Singapore: a national cohort study - The Lancet Infectious Diseases
Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design - The Lancet Infectious Diseases
What We Know So Far About Waning Vaccine Effectiveness - The New York Times
Vaccines and Boosters: Our Best Defense Against COVID-19
Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario - Ontario COVID-19 Science Advisory Table
Boosting immunity to COVID-19 vaccines | Nature Medicine
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years | Nature Medicine
Boosting immunity to Omicron | Nature Medicine
BioNTech SE on X: "95.6% relative vaccine efficacy against #Covid19 after a booster shot with our #mRNA vaccine, during a period when Delta was the prevalent strain. These are the first efficacy
Vaccines | Free Full-Text | The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021 - ScienceDirect
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
Vaccines | Free Full-Text | Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron | NEJM
Effectiveness of COVID-19 booster vaccination strategies in partially vaccinated populations